Day One Biopharmaceuticals, Inc. (DAWN)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch DAWN
See up to 3 months of DAWN. The 7-day demo opens the 1M and 3M ranges and puts DAWN on your watchlist.
Start 7-day demoLatest DAWN insider trades
Lauren Merendino - OfficerOpen-market sale$67K- Adam Dubow - OfficerOpen-market sale$74K
About Day One Biopharmaceuticals, Inc. (DAWN)
The SEC lists Day One Biopharmaceuticals, Inc. under CIK 0001845337, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
DAWN Form 4 activity by transaction type, last 90 days
No Form 4 activity for DAWN in the last 90 days.
DAWN insider transactions (Form 4)
14452 Form 4 filings on record, the earliest from Nov 4, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John A. Josey | Grant or award | Stock Option (right to buy Common Stock) | 28,700 | $0.00 | - | |
| John A. Josey | Derivative | Stock Option (right to buy Common Stock) | 37,500 | $0.00 | - | |
| John A. Josey | Grant or award | Stock Option (right to buy Common Stock) | 37,500 | $0.00 | - | |
| John A. Josey | Derivative | Stock Option (right to buy Common Stock) | 32,335 | $0.00 | - | |
| John A. Josey | Grant or award | Stock Option (right to buy Common Stock) | 32,335 | $0.00 | - | |
| John A. Josey | Derivative | Stock Option (right to buy Common Stock) | 63,000 | $0.00 | - | |
| John A. Josey | Grant or award | Stock Option (right to buy Common Stock) | 63,000 | $0.00 | - | |
| John A. Josey | Derivative | Stock Option (right to buy Common Stock) | 1,181 | $0.00 | - | |
| John A. Josey | Grant or award | Stock Option (right to buy Common Stock) | 1,181 | $0.00 | - | |
| John A. Josey | Derivative | Stock Option (right to buy Common Stock) | 28,700 | $0.00 | - | |
| William Grossman | Derivative | Stock Option (right to buy Common Stock) | 66,660 | $0.00 | - | |
| William Grossman | Grant or award | Stock Option (right to buy Common Stock) | 66,660 | $0.00 | - | |
| William Grossman | Derivative | Stock Option (right to buy Common Stock) | 32,335 | $0.00 | - | |
| William Grossman | Grant or award | Stock Option (right to buy Common Stock) | 32,335 | $0.00 | - | |
| Garry A. Nicholson | Derivative | Stock Option (right to buy Common Stock) | 33,900 | $0.00 | - | |
| Garry A. Nicholson | Grant or award | Stock Option (right to buy Common Stock) | 33,900 | $0.00 | - | |
| Garry A. Nicholson | Derivative | Stock Option (right to buy Common Stock) | 37,500 | $0.00 | - | |
| Garry A. Nicholson | Grant or award | Stock Option (right to buy Common Stock) | 37,500 | $0.00 | - | |
| Garry A. Nicholson | Derivative | Stock Option (right to buy Common Stock) | 32,335 | $0.00 | - | |
| Garry A. Nicholson | Grant or award | Stock Option (right to buy Common Stock) | 32,335 | $0.00 | - | |
| Natalie C. Holles | Grant or award | Stock Option (right to buy Common Stock) | 37,500 | $0.00 | - | |
| Natalie C. Holles | Derivative | Stock Option (right to buy Common Stock) | 32,335 | $0.00 | - | |
| Natalie C. Holles | Grant or award | Stock Option (right to buy Common Stock) | 32,335 | $0.00 | - | |
| Natalie C. Holles | Derivative | Stock Option (right to buy Common Stock) | 40,000 | $0.00 | - | |
| Natalie C. Holles | Grant or award | Stock Option (right to buy Common Stock) | 40,000 | $0.00 | - | |
| Natalie C. Holles | Derivative | Stock Option (right to buy Common Stock) | 40,300 | $0.00 | - | |
| Natalie C. Holles | Grant or award | Stock Option (right to buy Common Stock) | 40,300 | $0.00 | - | |
| Natalie C. Holles | Derivative | Stock Option (right to buy Common Stock) | 28,700 | $0.00 | - | |
| Natalie C. Holles | Grant or award | Stock Option (right to buy Common Stock) | 28,700 | $0.00 | - | |
| Natalie C. Holles | Derivative | Stock Option (right to buy Common Stock) | 37,500 | $0.00 | - | |
| Saira Ramasastry | Grant or award | Stock Option (right to buy Common Stock) | 40,000 | $0.00 | - | |
| Saira Ramasastry | Derivative | Stock Option (right to buy Common Stock) | 47,581 | $0.00 | - | |
| Saira Ramasastry | Grant or award | Stock Option (right to buy Common Stock) | 47,581 | $0.00 | - | |
| Saira Ramasastry | Derivative | Stock Option (right to buy Common Stock) | 28,700 | $0.00 | - | |
| Saira Ramasastry | Grant or award | Stock Option (right to buy Common Stock) | 28,700 | $0.00 | - | |
| Saira Ramasastry | Derivative | Stock Option (right to buy Common Stock) | 37,500 | $0.00 | - | |
| Saira Ramasastry | Grant or award | Stock Option (right to buy Common Stock) | 37,500 | $0.00 | - | |
| Saira Ramasastry | Derivative | Stock Option (right to buy Common Stock) | 32,335 | $0.00 | - | |
| Saira Ramasastry | Grant or award | Stock Option (right to buy Common Stock) | 32,335 | $0.00 | - | |
| Saira Ramasastry | Derivative | Stock Option (right to buy Common Stock) | 40,000 | $0.00 | - | |
| J. Scott Garland | Derivative | Stock Option (right to buy Common Stock) | 28,700 | $0.00 | - | |
| J. Scott Garland | Grant or award | Stock Option (right to buy Common Stock) | 28,700 | $0.00 | - | |
| J. Scott Garland | Derivative | Stock Option (right to buy Common Stock) | 37,500 | $0.00 | - | |
| J. Scott Garland | Grant or award | Stock Option (right to buy Common Stock) | 37,500 | $0.00 | - | |
| J. Scott Garland | Derivative | Stock Option (right to buy Common Stock) | 32,335 | $0.00 | - | |
| J. Scott Garland | Grant or award | Stock Option (right to buy Common Stock) | 32,335 | $0.00 | - | |
| J. Scott Garland | Derivative | Stock Option (right to buy Common Stock) | 48,072 | $0.00 | - | |
| J. Scott Garland | Grant or award | Stock Option (right to buy Common Stock) | 48,072 | $0.00 | - | |
| Adam Dubow - Officer | Grant or award | Stock Option (right to buy Common Stock) | 309,000 | $0.00 | - | |
| Adam Dubow - Officer | Derivative | Stock Option (right to buy Common Stock) | 90,000 | $0.00 | - | |
| Adam Dubow - Officer | Grant or award | Stock Option (right to buy Common Stock) | 90,000 | $0.00 | - | |
| Adam Dubow - Officer | Derivative | Stock Option (right to buy Common Stock) | 90,000 | $0.00 | - | |
| Adam Dubow - Officer | Grant or award | Stock Option (right to buy Common Stock) | 90,000 | $0.00 | - | |
| Adam Dubow - Officer | Derivative | Stock Option (right to buy Common Stock) | 90,000 | $0.00 | - | |
| Adam Dubow - Officer | Grant or award | Stock Option (right to buy Common Stock) | 90,000 | $0.00 | - | |
| Habib J. Dable | Derivative | Stock Option (right to buy Common Stock) | 66,660 | $0.00 | - | |
| Habib J. Dable | Grant or award | Stock Option (right to buy Common Stock) | 66,660 | $0.00 | - | |
| Habib J. Dable | Derivative | Stock Option (right to buy Common Stock) | 32,335 | $0.00 | - | |
| Habib J. Dable | Grant or award | Stock Option (right to buy Common Stock) | 32,335 | $0.00 | - | |
| Charles N. York II - Officer | Derivative | Stock Option (right to buy Common Stock) | 116,000 | $0.00 | - | |
| Charles N. York II - Officer | Grant or award | Stock Option (right to buy Common Stock) | 116,000 | $0.00 | - | |
| Charles N. York II - Officer | Derivative | Stock Option (right to buy Common Stock) | 162,000 | $0.00 | - | |
| Charles N. York II - Officer | Grant or award | Stock Option (right to buy Common Stock) | 162,000 | $0.00 | - | |
| Charles N. York II - Officer | Derivative | Stock Option (right to buy Common Stock) | 162,000 | $0.00 | - | |
| Charles N. York II - Officer | Grant or award | Stock Option (right to buy Common Stock) | 162,000 | $0.00 | - | |
| Charles N. York II - Officer | Derivative | Stock Option (right to buy Common Stock) | 497,667 | $0.00 | - | |
| Charles N. York II - Officer | Grant or award | Stock Option (right to buy Common Stock) | 497,667 | $0.00 | - | |
| Charles N. York II - Officer | Derivative | Stock Option (right to buy Common Stock) | 151,000 | $0.00 | - | |
| Charles N. York II - Officer | Grant or award | Stock Option (right to buy Common Stock) | 151,000 | $0.00 | - | |
 Jeremy Bender - Officer | Option exercise | Common Stock | 3,562 | - | - | |
| Jeremy Bender - Officer | Option exercise | Common Stock | 4,750 | - | - | |
| Jeremy Bender - Officer | Option exercise | Common Stock | 11,687 | - | - | |
| Jeremy Bender - Officer | Option exercise | Common Stock | 11,687 | - | - | |
| Jeremy Bender - Officer | Open-market sale | Common Stock | 16,058 | $6.77 | $109K | |
| Jeremy Bender - Officer | Option exercise | Restricted Stock Unit (RSU) | 3,562 | $0.00 | - | |
| Jeremy Bender - Officer | Option exercise | Restricted Stock Unit (RSU) | 4,750 | $0.00 | - | |
| Jeremy Bender - Officer | Option exercise | Restricted Stock Unit (RSU) | 11,687 | $0.00 | - | |
| Jeremy Bender - Officer | Option exercise | Restricted Stock Unit (RSU) | 11,687 | $0.00 | - | |
| Lauren Merendino - Officer | Option exercise | Common Stock | 3,162 | - | - | |
| Lauren Merendino - Officer | Option exercise | Common Stock | 3,687 | - | - | |
| Lauren Merendino - Officer | Option exercise | Common Stock | 3,687 | - | - | |
| Lauren Merendino - Officer | Open-market sale | Common Stock | 3,766 | $6.77 | $25K | |
| Lauren Merendino - Officer | Option exercise | Restricted Stock Unit (RSU) | 3,162 | $0.00 | - | |
| Lauren Merendino - Officer | Option exercise | Restricted Stock Unit (RSU) | 3,687 | $0.00 | - | |
| Lauren Merendino - Officer | Option exercise | Restricted Stock Unit (RSU) | 3,687 | $0.00 | - | |
| Adam Dubow - Officer | Option exercise | Common Stock | 2,963 | - | - | |
| Adam Dubow - Officer | Option exercise | Common Stock | 1,750 | - | - | |
| Adam Dubow - Officer | Option exercise | Common Stock | 3,687 | - | - | |
| Adam Dubow - Officer | Option exercise | Common Stock | 3,687 | - | - | |
| Adam Dubow - Officer | Open-market sale | Common Stock | 4,365 | $6.77 | $30K | |
| Adam Dubow - Officer | Option exercise | Restricted Stock Unit (RSU) | 2,963 | $0.00 | - | |
| Adam Dubow - Officer | Option exercise | Restricted Stock Unit (RSU) | 1,750 | $0.00 | - | |
| Adam Dubow - Officer | Option exercise | Restricted Stock Unit (RSU) | 3,687 | $0.00 | - | |
| Adam Dubow - Officer | Option exercise | Restricted Stock Unit (RSU) | 3,687 | $0.00 | - | |
| Charles N. York II - Officer | Option exercise | Common Stock | 1,375 | - | - | |
| Charles N. York II - Officer | Option exercise | Common Stock | 2,250 | - | - | |
| Charles N. York II - Officer | Option exercise | Common Stock | 6,625 | - | - | |
| Charles N. York II - Officer | Option exercise | Common Stock | 6,625 | - | - | |
| Charles N. York II - Officer | Open-market sale | Common Stock | 4,106 | $6.77 | $28K | |
| Charles N. York II - Officer | Option exercise | Restricted Stock Unit (RSU) | 1,375 | $0.00 | - | |
| Charles N. York II - Officer | Option exercise | Restricted Stock Unit (RSU) | 2,250 | $0.00 | - | |
| Charles N. York II - Officer | Option exercise | Restricted Stock Unit (RSU) | 6,625 | $0.00 | - | |
| Charles N. York II - Officer | Option exercise | Restricted Stock Unit (RSU) | 6,625 | $0.00 | - | |
| Jeremy Bender - Officer | Gift | Common Stock | 148,312 | $0.00 | - | |
| Jeremy Bender - Officer | Gift | Common Stock | 148,312 | $0.00 | - | |
| Jeremy Bender - Officer | Gift | Common Stock | 74,328 | $0.00 | - | |
| Jeremy Bender - Officer | Gift | Common Stock | 74,328 | $0.00 | - | |
| Jeremy Bender - Officer | Gift | Common Stock | 199,202 | $0.00 | - | |
| Jeremy Bender - Officer | Gift | Common Stock | 199,202 | $0.00 | - | |
| Jeremy Bender - Officer | Gift | Common Stock | 179,417 | $0.00 | - | |
| Jeremy Bender - Officer | Gift | Common Stock | 179,417 | $0.00 | - | |
| Samuel C. Blackman - Officer | Open-market sale | Common Stock | 30,000 | $13.31 | $399K | |
| Jeremy Bender - Officer | Option exercise | Common Stock | 3,562 | - | - | |
| Jeremy Bender - Officer | Option exercise | Common Stock | 4,750 | - | - | |
| Jeremy Bender - Officer | Option exercise | Common Stock | 11,687 | - | - | |
| Jeremy Bender - Officer | Open-market sale | Common Stock | 10,554 | $13.21 | $139K | |
| Jeremy Bender - Officer | Option exercise | Restricted Stock Unit (RSU) | 3,562 | $0.00 | - | |
| Jeremy Bender - Officer | Option exercise | Restricted Stock Unit (RSU) | 4,750 | $0.00 | - | |
| Jeremy Bender - Officer | Option exercise | Restricted Stock Unit (RSU) | 11,687 | $0.00 | - | |
| Samuel C. Blackman - Officer | Option exercise | Common Stock | 1,187 | - | - | |
| Samuel C. Blackman - Officer | Option exercise | Common Stock | 1,437 | - | - | |
| Samuel C. Blackman - Officer | Option exercise | Common Stock | 6,062 | - | - | |
| Samuel C. Blackman - Officer | Open-market sale | Common Stock | 2,206 | $13.21 | $29K | |
| Samuel C. Blackman - Officer | Option exercise | Restricted Stock Unit (RSU) | 1,187 | $0.00 | - | |
| Samuel C. Blackman - Officer | Option exercise | Restricted Stock Unit (RSU) | 1,437 | $0.00 | - | |
| Samuel C. Blackman - Officer | Option exercise | Restricted Stock Unit (RSU) | 6,062 | $0.00 | - | |
| Adam Dubow - Officer | Option exercise | Common Stock | 2,962 | - | - | |
| Adam Dubow - Officer | Option exercise | Common Stock | 1,750 | - | - | |
| Adam Dubow - Officer | Option exercise | Common Stock | 3,687 | - | - | |
| Adam Dubow - Officer | Open-market sale | Common Stock | 3,165 | $13.21 | $42K | |
| Adam Dubow - Officer | Option exercise | Restricted Stock Unit (RSU) | 2,962 | $0.00 | - | |
| Adam Dubow - Officer | Option exercise | Restricted Stock Unit (RSU) | 1,750 | $0.00 | - | |
| Adam Dubow - Officer | Option exercise | Restricted Stock Unit (RSU) | 3,687 | $0.00 | - | |
| Charles N. York II - Officer | Option exercise | Common Stock | 1,375 | - | - | |
| Charles N. York II - Officer | Option exercise | Common Stock | 2,250 | - | - | |
| Charles N. York II - Officer | Option exercise | Common Stock | 6,625 | - | - | |
| Charles N. York II - Officer | Open-market sale | Common Stock | 2,602 | $13.21 | $34K | |
| Charles N. York II - Officer | Option exercise | Restricted Stock Unit (RSU) | 1,375 | $0.00 | - | |
| Charles N. York II - Officer | Option exercise | Restricted Stock Unit (RSU) | 2,250 | $0.00 | - | |
| Charles N. York II - Officer | Option exercise | Restricted Stock Unit (RSU) | 6,625 | $0.00 | - | |
| Samuel C. Blackman - Officer | Open-market sale | Common Stock | 18,255 | $16.17 | $295K | |
| Samuel C. Blackman - Officer | Open-market sale | Common Stock | 10,000 | $16.10 | $161K | |
| Samuel C. Blackman - Officer | Open-market sale | Common Stock | 11,245 | $16.03 | $180K | |
| Samuel C. Blackman - Officer | Open-market sale | Common Stock | 500 | $16.02 | $8K |
Item 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Item 9.01
Item 1.01, 8.01, 9.01
Item 7.01, 9.01
DAWN insider trading FAQ
What is the latest insider trade for DAWN?
Day One Biopharmaceuticals, Inc. (DAWN) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-04-27. The full record for DAWN runs to 52 Form 4 filings, the earliest from 2024-11-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying DAWN stock?
No insider purchases of DAWN were filed in the last 90 days.
How many insiders are selling DAWN stock?
No insider sales of DAWN were filed in the last 90 days. 22 sales are on record for this company.
Where can I see DAWN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects DAWN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - AI Day1 LLC view on EDGAR
- - Jeremy Bender view on EDGAR
- - Michael Vasconcelles view on EDGAR
- - Charles N. York II view on EDGAR
- - Adam Dubow view on EDGAR
- - Natalie C. Holles view on EDGAR
- - Saira Ramasastry view on EDGAR
- - John A. Josey view on EDGAR
- - J. Scott Garland view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where DAWN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow DAWN with a 7-day demo
- DAWN on your watchlist
- Every DAWN Form 4 filing on record
- Up to 3 months of DAWN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
